Investors / Eisai Innovation Inc.
Eisai Innovation Inc.
Corporate VC
Eisai Innovation Inc. is a strategic investment organization that looks for synergies between the scientific community and the Eisai network of companies. It makes global investments and pursues research collaborations aimed at disease prevention, prediction, and treatment.
Invests inHealthcare & Biotech
In its own wordsneurologyoncologydigital healthdiagnosticsbiotechcorporate venture
Your fit with Eisai Innovation Inc.
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsEisai Innovation Inc. lists 26 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Seed, 33% of the companies with a known first round. Its largest themes are Healthcare & Biotech (96%) and Consumer (4%). 55% of its companies are based in United States. It invests most often alongside Apricot Capital, Catalio Capital Management and Spacestation Investments.
Counts come from funding rounds that name Eisai Innovation Inc., complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Eisai Innovation Inc.'s whole history. Rounds on record name 3 companies; its own site lists 26. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundEisai Innovation Inc. does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 33% |
| Series A | 33% |
| Series B | 0% |
| Growth | 33% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 62th | 26 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 64th | 33% of entries at pre-seed or seed |
| Evidence | 80th | 12% of companies confirmed by a round |
| Sector focus | 97th | 96% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Apricot Capital | 2 |
| Catalio Capital Management | 2 |
| Spacestation Investments | 2 |
| Wellington Partners | 2 |
| b2venture | 2 |
| 15th Rock | 1 |
| 5Y Capital | 1 |
| 8VC | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2492%
- No longer answers00%
- Points to another company28%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 96% | 15% |
| Consumer | 4% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Eisai Innovation Inc. head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Eisai Innovation Inc.| Date | Company | Stage |
|---|---|---|
| 10 Jun 2026 | Series C+ | |
| 29 Apr 2026 | Series A | |
| 18 Feb 2026 | Seed |
Round details for Eisai Innovation Inc.
Amounts, full round histories and every co-investor in Eisai Innovation Inc.'s rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
26 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company provides healthcare solutions, including remote medical care support and medical care network services. | Healthcare & Biotech | Portfolio page | ||
| Altoida develops a digital platform to detect early cognitive decline and provide neurological diagnostics | Healthcare & Biotech | Portfolio page | ||
| Arteryex supports healthcare and healthcare businesses with PHR data utilization | Healthcare & Biotech | Portfolio page | ||
| Beren Therapeutics develops medicines to address the root cause of diseases | Healthcare & Biotech | Jun 2026Series C+ | Page + round | |
| BlissBio has developed into a clinical-stage biotech company dedicated to the discovery, development and commercialization of oncology biological therapeutics. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Casma Therapeutics is developing novel cellular degradation approaches based on the autophagy pathway to initiate new target areas for drug discovery and development | Healthcare & Biotech | Portfolio page | ||
| Darmiyan develops medical AI and brain imaging software for precision brain health screening and monitoring | Healthcare & Biotech | Portfolio page | ||
| eGenesis develops human-compatible organs for patients with organ failure using genome engineering and transplantation | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Hyku Biosciences is developing small molecule therapeutics with novel mechanisms of action to potently inactivate proteins that drive disease progression. | Healthcare & Biotech | Portfolio page | ||
| Iambic Therapeutics develops medicines using artificial intelligence and molecular technologies | Healthcare & Biotech | Portfolio page | ||
| Neuroglee Health provides comprehensive memory and dementia care and support for care partners | Healthcare & Biotech | Portfolio page | ||
| Numab Therapeutics engineers multispecific antibodies | Healthcare & Biotech | Portfolio page | ||
| Ophidion is an early-stage CNS biopharmaceutical company that develops non-invasive carrier technology for delivering therapeutics across the blood-brain barrier into the brain. | Healthcare & Biotech | Portfolio page | ||
| Oura provides a smart ring that tracks various health metrics, including sleep, activity, stress, and more, and offers personalized insights through its app. | Healthcare & BiotechConsumer | Portfolio page | ||
| Prism Biolab develops new drugs using its PepMetics technology | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Ractigen Therapeutics is a clinical-stage pharmaceutical company creating first-in-class therapies designed to boost expression of therapeutic genes in diseased cells. | Healthcare & Biotech | Portfolio page | ||
| SEED Therapeutics develops molecular glue degraders for targets beyond the reach of traditional therapies | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- eisaiinnovation.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 18 Feb 2026
- Companies checked
- 26
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Eisai Innovation Inc.'s profile as data
Pull Eisai Innovation Inc.'s portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/eisaiinnovation.com
# also
GET /v1/firms/eisaiinnovation.com/portfolio
GET /v1/firms/eisaiinnovation.com/coinvestors
GET /v1/firms/eisaiinnovation.com/news